Theseus Pharmaceuticals
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
SHAKESPEARE WILLIAM officer: See Remarks
 Common Stock 251,084 $0.32 $80,347
Option
SHAKESPEARE WILLIAM officer: See Remarks
 Stock Option (right to buy) 251,084 $0.32 $80,347
Purchase
GORDON CARL L director, 10 percent owner:
Common Stock 328,482 $3.05 $1,001,870
Purchase
GORDON CARL L director, 10 percent owner:
Common Stock 151,450 $3.05 $461,923
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner:
Common Stock 328,482 $3.05 $1,001,870
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner:
Common Stock 151,450 $3.05 $461,923
Purchase
FORESITE CAPITAL MANAGEMENT V, LLC 10 percent owner
 Common Stock 523,450 $2.97 $1,554,647
Purchase
FORESITE CAPITAL MANAGEMENT V, LLC 10 percent owner
 Common Stock 176,550 $2.97 $524,354
Purchase
HAYDEN DONALD J JR director
 Common Stock 9,900 $5 $49,490
Purchase
FORESITE CAPITAL MANAGEMENT V, LLC 10 percent owner
 Common Stock 250,000 $5 $1,250,000
Purchase
FORESITE CAPITAL MANAGEMENT V, LLC 10 percent owner
 Common Stock 250,000 $5 $1,250,000
Purchase
HAYDEN DONALD J JR director
 Common Stock 100 $5 $500
Purchase
DAHMS BRADFORD D. officer: Chief Financial Officer
 Common Stock 1,502 $6.66 $9,999
Purchase
CLACKSON TIMOTHY P director, officer: President an..
 Common Stock 2,500 $6.8 $16,995
Purchase
GORDON CARL L director, 10 percent owner
 Common Stock 192,000 $5.21 $1,000,320
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
 Common Stock 192,000 $5.21 $1,000,320
Purchase
GORDON CARL L director, 10 percent owner
 Common Stock 111,896 $9.97 $1,115,603
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
 Common Stock 111,896 $9.97 $1,115,603
Purchase
GORDON CARL L director, 10 percent owner
 Common Stock 35,000 $9.95 $348,250
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
 Common Stock 35,000 $9.95 $348,250
Purchase
GORDON CARL L director, 10 percent owner
 Common Stock 11,521 $9.97 $114,864
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
 Common Stock 11,521 $9.97 $114,864
Purchase
GORDON CARL L director, 10 percent owner
 Common Stock 17,320 $9.43 $163,328
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
 Common Stock 17,320 $9.43 $163,328
Purchase
GORDON CARL L director, 10 percent owner
 Common Stock 18,897 $10.06 $190,104
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
 Common Stock 18,897 $10.06 $190,104
Purchase
GORDON CARL L director, 10 percent owner
 Common Stock 8,500 $10.24 $87,040
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
 Common Stock 8,500 $10.24 $87,040
Purchase
DAHMS BRADFORD D. officer: Chief Financial Officer
 Common Stock 1,970 $10.15 $19,999
Purchase
CLACKSON TIMOTHY P director, officer: President an..
 Common Stock 2,600 $9.76 $25,381
Purchase
SHAKESPEARE WILLIAM officer: President of Research ..
 Common Stock 625 $16 $10,000
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
 Common Stock 625,000 $16 $10,000,000
Purchase
ROCK SPRINGS CAPITAL MANAGEMENT LP 10 percent owner
 Common Stock 250,000 $16 $4,000,000
Purchase
GORDON CARL L director, 10 percent owner
 Common Stock 625,000 $16 $10,000,000
Purchase
OMEGA FUND VI, L.P. other
 Common Stock 187,500 $16 $3,000,000

Showing 1 to 35 of 35 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: